Bashmakov 2014 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Bhatt 2013 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Bo 2018 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Elliott 2009 |
Narrative review |
Fujitaka 2011 |
Study participants had metabolic syndrome. Primary investigator for that study was Dipak K Das, who was found to have falsified data and was charged with fraud (https://www.nytimes.com/2012/01/12/science/fraud‐charges‐for‐dipak‐k‐das‐a‐university‐of‐connecticut‐researcher.html) |
Goh 2014 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Imamura 2017 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Javid 2017 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Khazaei 2014 |
Narrative review |
Khodabandehloo 2018 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Kjaer 2014 |
Study participants had metabolic syndrome |
Mendez‐Del 2014 |
Study participants had metabolic syndrome |
Movahed 2014 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
NCT00937222 |
Study intervention was not resveratrol (peanuts and peanut butter intervention) |
NCT01038089 |
Not a randomised controlled trial |
NCT01150955 |
Study participants had metabolic syndrome |
NCT01375959 |
Study participants had impaired glucose tolerance |
NCT01714102 |
Study participants did not have type 2 diabetes mellitus |
NCT01997762 |
Study participants had gestational diabetes |
NCT02129595 |
Study participants did not have type 2 diabetes mellitus |
NCT02216552 |
Study participants did not have type 2 diabetes mellitus |
NCT02219906 |
Study participants had metabolic syndrome |
NCT02565979 |
Study participants had impaired glucose homeostasis |
Sattarinezhad 2018 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Seyyedebrahimi 2018 |
Study participants were not comparable due to a combination of a rather unspecified mixture of oral anti‐diabetic agents with/without resveratrol (not identical in the intervention/comparator groups) |
Tomé‐Carneiro 2012 |
Only 36% to 48% of study participants had type 2 diabetes mellitus |